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Summary: A simple and fast HPLC method for the determination of ροφΗγπηβ in bile without extraction is
described. ΡθφΗγΗη8 were determined in bile from control subjects and from patients after orthotopic liver trans-
plantation, ineluding three patients with eiythropoietic protoporphyria. It was found that:
1) coproporphyrin I is the predominant porphyrin in bile of controls, accompanied by some coproporphyrin III and
protoporphyrin, whereas protoporphyrin mostly but not always is the predominant porphyrin in the bile of erythro-
poietic protoporphyria patients. In two of the three erythropoietic protoporphyria patients, the bile contained a
hundred times more protoporphyrin than that of ήοη-porphyric orthotopic liver transplantation patients. The third
erythropoietic protpporphyria patient remained cholestatic and was unable to excrete sufficient amounts of protopor-
phyrin.
2) All investigated bile samples contained no secondary porphyrins derived from protoporphyrin, i. e. no deutero-,
pempto-, or mesoporphyrin. Even when extracts of bile and serum were concentrated fifty to a hundred times, no
traces of deutero^, pempto- and mesoporphyrin were detected. This complete absence of secondary porphyrins
suggests that an enterohepatic circulation of dicarb xylic porphyrins from the distal gastrointestinal tract does
not exist.
3) The HPLC chromatqgfarns contain peaks from unknown compounds. No correlation between ροφ!^τίη8 and
these compounds was found.
Porphyrin profiles were followed in the bile of some orthotopic liver transplantation patients. Three episodes are
recognizable. D ring the first three days after orthotopic liver transplantation there is a very high οορΓοροφΙ^ιίη
excretion. There is then a lag of one to three weeks, in which no or very low ρoφhyrin concentrations are detectable,
followed by the restoration of normal biliary ροφίιγιίη patterns.
Introduction The poφhyric diseases can be identified by profiling of
urine, faeces or blood (1—3), and detecting the ροφίν/-
Determination of ροφίι^η profiles in biological sain-
 rins that are ffQ^y elevated. Thus, together with their
plesbyrneansofHPLChasprovedvaluableinthediag- clinical presentation, congenital erythropoietic por-
nosis and treatment of patiemts suffering from currently phyria, poφhyria cutanea tarda and attacks of acute in-
knownforms ofpoφhyria, allcausedby adeficiency or termittent poφhyria can be identified by analysis of
Inhibition of enzymes involved in the synthesis of haem. urine, whereas stool analysis is needed to identify at-
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tacks of hereditary coproporphyria and variegate por-
phyria. Erythropoietic protoporphyria can be confirmed
by analysis of the protoporphyrin content of erythro-
cytes. In many clinical laboratories, such determinations
are presently performed on a routine basis.
So far, not much attention has been paid to porphyrin
profiles in human bile, since the diagnosis and follow
up of porphyria can be satisfactorily carried out by ana-
lysing urine, faeces or blood. However, for asymptom-
atic patients with porphyria those methods are not al-
ways sufficiently discriminatory. Bile was recently suc-
cessfully used for the evaluation of asymptomatic pa-
tients with variegate porphyria (4). For some weeks
following orthotopic liver transplantation, which is a
regulär Operation in our hospital, bile is removed via a
T-drain. For the following reasons, we decided to exploit
this ready source, in order to determine the porphyrin
composition of bile. First, the HPLC method, practised
in our laboratory for the specific determination of por-
phyrins, ahalyses a wide variety of biological samples,
using simple and essentially similar purification Steps.
Therefore we expected no problems in adapting the
method for the analysis of bile. Secondly, three of the
many patients underwent transplantation following liver
failure due to longstanding erythropoietic protopor-
phyria. In this disease protoporphyrin is produced in ab-
normal amounts, mainly in erythrocytes and also in
liver, due to ferrochelatase deficiency. The hydrophobic
protoporphyrin molecules accumulate in the liver and
have to be removed by excretion in bile. Although proto-
porphyrin is potentially toxic, most erythropoietic proto-
porphyria patients manage to preserve a reasonable liver
fiinction, because the raised quantity of produced proto-
porphyrin can still be adequately excreted in the bile.
However, after the gradual accumulation of protopor-
phyrin, some erythropoietic protoporphyria patients suf-
fer from irreversible liver damage and finally liver fail-
ure, requiring orthotopic liver transplantation in order to
survive (5-10). After transplantation, the patients have
to be monitored regularly for the ability of the liver to
adequately excrete the continuing excessive production
of protoporphyrin from bone marrow, because of the risk
of renewed liver failure (9). For these reasons we con-
sidered it of clinical interest to compare the biliary
excretion of porphyrins of erythropoietic protoporphyria
patients in the weeks after orthotopic liver transplanta-
tion with that of orthotopic liver transplantation patients
operated for liver failure from other diseases.
Further we had at our disposal a number of samples
from different patients after duodenal intubation, i. e. A
bile (fasting duodenal content), B (gall bladder) bile and
C (hepatic) bile. The porphyrin profiles of these samples
were investigated and compared with bile from or-
thotopic liver transplantation patients.
Since none of the bile samples contained traces of por-
phyrins derived frorn the bacterial conversion ofendoge-
nous porphyrins in the gut (i. e. secondary porphyrins
like meso-, pempto- and deuteroporphyrin (3)), we rein-
vestigated the controversial issue of the existence of an
enterohepatic cireulation for porphyrins (11 — 14). For
this purpose large amounts of bile and serum were puri-
fied for analysis of porphyrins. These concentrated ex-
tracts were investigated for the presence of secondary
porphyrins, but these appeared to be absent. As dis-
cussed in this päper, this does not support the hypothesis
that dicarboxylic porphyrins, including protoporphyrin,
are subject to enterohepatic cireulation from the lower
gastrointestinal tract. Altogether the results of HPLC
porphyrin profiling in human bile described in this paper
confirm that such determinations constitute a useM ex-
tension of the available procedures for pofphyrm profil-
ing in clinical laboratories in certain clinical conditions.
Materials and Methods
Patients and samples
Porphyrins were studied in the bile of two different groups of pa-
tients. The first group of six subjects had undergone an orthotopic
liver transplantation, three of thera on account of erythropoietic
protoporphyria. The second group consisted of 11 subjects who for
different reasons were intubated for gall bladder investigations. The
orthotopic liver transplantation procedure in our hospital has been
described earlier (15). The biliary procedure was ari end-to-end
choledochocholedochostomy over a bile-tube and removal of the
gall bladder. After 3—4 weeks, or later if indicated, the tube was
clamped, then removed after some days.
The intubation procedure to obtain A-, B-, and C-bile was de-
scribed previously (16). The intubation was performed in patients
who had fasted for at least 14 hours; a plastic tube with a metallic
end was positioned in the third part of the duodenum, using fluo-
roscopic monitoring. A-bile (fasting duodenal contents, consisting
of secretions from the pancreas, bile ducts and duodenum) was
aspirated, whereafter contraction of the gall bladder was stimuläted
by intravenous administration of cholecystokinin. Within 10-15
minutes after the injection, dark gall bladder bile was aspirated (ß-
bile). After 45 to 60 minutes a third sample of light-coloured aspi-
rate was drawn (C-bile). This C-bile consists mainly of hepatic bile
with pancreatic and duodenal secretions (16).
Bile samples of the patients were obtained with regard to the rules
of the Medical Ethical Committee of our hospital. The samples
were protected from light äs much äs possible and were stored
frozen without preservation prior to analysis.
Porphyrin analysis
Bile
Two-hundred of bile, 200 of 3 mol/1 HC1 and 100 of an
internal Standard solution (500 nmol/1 deuteroporphyrin (Porphyrin
Products, Logan, USA) in a 0.8 rnol/1 sülphosalicylic acid solution)
were mixed in an Eppendorf cup. After centrifugation, 40 of the
clear supernatant was injeeted onto the HPLC column.
The porphyrins of bile were eluted under the same conditions äs
porphyrins of urine, blood and faeces. Details of these methods
including the use of internal Standard were described previously
(2,3).
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During the development of the determination of porpbyrins in bile
ihe sample volume and its predil tions were chosen so that normal
bile samples give peak heights comparable to those seen in normal
urine, blood and faecal samples.
Traces in bile
For the determination of traces of porphyrins in bile the following
procedure was used. A bile solution of 100 ml, obtained from frac-
tions of bile of different subjects, was divided into two equal por-
tions. To one portion the internal Standard deuteropoφhyrin was
added. Porphyrins were extracted twice with 100 ml of a freshly
prepared ether — glacial acetic acid solution (3 4- l, by vol.). In a
waterbath set at 37 °C the extracts were evaporated to dryness by
means of a nitrogen stream. The poφhyrins were dissolved in l ml
of 6 mol/1 HC1 solution, and 40 μΐ of the acid solution was injected
onto the HPLC cohimn.
Traces in serum
Due to the low ροφηνπη and high protein concentrations in serum
compared with bile, the ροφηνπη extraction procedure for serum
completely differs from that of bile. The porphyrins were extracted
according to a combination of methods described by Falk (17).
Briefly, a portion of 200 ml serurn, pooled trom more than 50
different subjects, was divided into two equal portions. To one por-
tion the internal Standard deuteropoφhyrin was added. To the sera
a tnixture of 500 ml of ethyl acetate and glacial acetic acid (3 +
l, by vol.) was added slowly with vigorous stirring and the mix-
tures were allowed to stand for three hours. The precipitated pro-
teins were removed on a B chner funnel, and washed well two
times with 100 ml of an ethyl acetate — acetic acid mixture (3+1,
by vol.). The protein residues may still contain considerable
amounts of ωΌροφηνπηε, but since we were concerned only with
tetra- and dicarboxyiic ροφηντίη8 ηο further attention was paid
to the ιίΓοροφηνπηε. The combined filtrates were transferred to a
separating funnel, and washed twiee with 300 ml of a saturated
sodium acetate solution. The washings were extracted twice with
100 ml of ethyl acetate. The ethyl acetate layers were added to the
main ethyl acetate — acetic acid layers. The combined ethyl acetate
layers were washed once with 100 ml of 0.2 mol/1 sodium acetate
solution. The ροφηνπηβ were extracted completely from the ethyl
acetate — acetic acid solution with 2 portions of 50 ml f a 4 mol/1
HC1 solution. In a separating funnel the ροφ!τνπη8 were transfer-
red from the combined HC1 extract into 500 ml ether by adjusting
the pH to about 4 with a solution of 4 rool/1 NaOH and 50 ml of a
saturated sodimn acetate solution. The mixture was shaken fre-
quently thus preventing precipitation of ροφηνπη$. The aqueous
layers were re-extracted twice with fresh ether, and the ether frac-
tions were combined. The combined ether layers were washed once
with 100 ml of 0.2 mol/1 sodiurn acetate solution, arid their volumes
were reduced by 95% under a nitrogen stream. The ροφίννπηβ
were extracted in 500 μΐ of 6 mol/1 HC1, and 200 μΐ of this solution
was injected onto the HPLC columii.
Reproducibility, linearity and recovery
The intra-rassay coefficient of Variation of the method was deter-^
mined with bile containing normal οορΓοροφΙ^πη Ι and III con-
centrations and a high content of ρΓΟίοροφΙ^πη (2.5 μηηοΐ/ΐ). This
sample was assayed 10 times in the same run. The linearity of
the method was determined by analysing two biles with a high
ΰορΓοροφηντίη I and ρίοίοροφηντΐη content, respectively, in
increasing volumes (10, 20, 50, 100, 200, 300, and 400 μΐ) to
which 100 μΐ of internal Standard and HC1 solution (3 mol/1) were
added to an end volurne of 600 μΐ. The recoveries of οορΓοροφΙιν-
rin I and ρπΛοροφηντίη were determined in normal bile fortified
with 100 and 30 nmol/J, respectively.
Results
Chromatograms of bile porphyrins after orthotopic liver
transplantation are shown in figure l (la and Ic, non-
erythropoietic protoporphyria patients; Ib and Id, a sin-
gle patient at different times after orthotopic liver trans-
plantation). The following porphyrins were found to be
present in bile: coproporphyrin I and III (peaks num-
bered l and 2) and protoporphyrin (peak 4). Clearly the
erythropoietic protoporphyria patient excretes consider-
ably more protoporphyrin in bile. From figure l, one
can further deduce that bile contains no pempto-, and
mesoporphyrin (peaks numbered 7 and 8), while deuter-
oporphyrin (peak 3) also appeared to be absent when
omitted s an internal Standard (not shown in fig. 1). In
order to ascertain that bile and serum contained not even
traces of these porphyrins, we concentrated normal bile
and serum extracts about fifty to two hundred times
(compared with routine procedures) and injected these
extracts onto the HPLC column. The results of these
experiments are shown in figure 2 (2a: bile with, 2b:
bile without internal Standard, 2c: serum with internal
Standard, 2d: plain serum) and they demonstrate again
that no traces of deutero-, pempto-, and mesoporphyrin
are present in bile or serum. There is therefore no objec-
tion taking deuteroporphyrin s the internal Standard for
the determination of biliary porphyrins. Figures l and 2
show that peaks (numbered 5 and 6) of unknown com-
pounds are also found, eluting between copro- and deut-
eroporphyrin. Investigation of many other bile samples
revealed that the peak heights of these unknown com-
pounds did not correlate with those of protoporphyrin
(see for example the chromatograms shown in fig. 1).
25 0
Retention time [min ]
Fig. l Chromatograrns of ροφ1^πη$ in bile of patients vvho un-
derwent an orthotopic liver transplantation. Chromatograms l a and
Ic are obtained from patients not suffering from a ροφί^π'ο dis-
ease. Depicted are ροφίψπηδ in bile two days (Ic) and three weeks
(la) after orthotopic liver transplantation. Chromatogram Ib and
Id are from one patient with erythropoietic ρπ>1οροφη>α^, 50 and
56 d ys after orthotopic liver transplantation, respectively. Bile for
Id was collected during a surgical Operation for peptic ulceration.
Numbering:
l = οορΓοροφηντίη I, 2 = οορΓοροφΙ^πη III, 3 = internal Stan-
dard deuteropoφhyrin, 4 = ρΓΟΙοροφηντίη, 5 and 6 unkno\vn com-
pounds, 7 = ρεηιρίοροφηνπη, 8 = ηιοβοροφηνπη.
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Because of their porphyric-like fluorescence it is tempt-
ing to speculate that these unknown compounds possess
a porphyrin structure. Although of potential clinical in-
terest, we have not attempted to study further the nature
of the compounds represented by these peaks.
Figure 3 shows data for the time course of concentration
changes of coproporphyrin I and protoporphyrin in bile
of different patients after orthotopic liver transplant -
tion. Figures 3a and 3b represent results of three erythro-
poietic protoporphyria patients (one of them died half a
year after orthotopic liver transplantation, the other two
10 25 10
Retention time [min ]
25
Fig. 2 Chromatograms of porphyrins in extracts of bile and se-
rum, showing the absence of secondary porphyrins in these body
fluids. Bile (2a and 2b) is concentrated fifty, and serum (2c and 2d)
two hundred times: To the extracts 2a and 2c, the internal Standard
deuteroporphyrin was added, to final concentrations of 50 and 75
nmol/l, respectively.
For explanations of the numbers see figure l.
In both serum and bile, eoproporphyrin I is the most prominent
poφhyΓin. the copro I/proto ratio in this serura pool is 4.4. The
estimated protoporphyrin concentration in the serum pool is about
70 pmol/l.
are still alive three years after orthotopic liver transplan-
tation). Figures 3c and 3d depict results of three or-
thotopic liver transplantation subjects, who were trans-
planted because of primary biliary cirrhosis (n = 1),
chronic active (n = 1) and inactive cirrhosis (n = 1).
Table l presents a survey of the resuits of porphyrin
concentrations in A^, B-, and C-bile of a nurnber of pa-
tients.
The coefficients of Variation for intra-nm precisions
measured for coproporphyrin I, coproporphyrin ΙΠ and
protoporphyrin were 2.1, 5.3 and 1.1% (n = 10), respec-
tively. The method was linear up to 4 μιηοΐ/l for all por-
phyrins, while recoveries for coproporphyrin I and pro-
topoiphyrin were > 95%.
Discussion
Reports of determinations of porphyrins in bile are
scanty, partly due to the fact that bile is not easily avail-
able and partly because nalysis of bile is not essential
for the diagnosis and follow up of porphyric patietits.
However, in a recent report, the nalysis of porphyrins
in bile proved to be superior to the nalysis in faeces in
establishing the diagnosis of variegate porphyria, s the
difference between normal and pathological porphyrin
excretions in bile was greater than in faeces (4). More-
over, investigation of biliary porphyrins provides infor^
mation on the ability of the liver to excrete the different
porphyrins. In contrast to uro- and coproporphyrins,
highly hydrophobic protopoφhyrin can only be excreted
in bile, hepatic secretion being rate limiting (19). In the
case of erythropoietic protoporphyria, the increased
blood protopoφhyrin tends to accumul te in the liver,
which firstly can lead to cholestasis and eventually t
Copro 1
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Copro 1 1
15 25
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Fig. 3 Time course profiles of coproporphyrin I (copro Γ) and pro- ure 3c and 3d profiles of three non-porphyric patients are depicted.
tppoφhyrm (proto) in bile of patients who underwent an orthotopic The solid line in figure 3a and 3b represents the erythropoietic
liver transplantation. In figure 3a and 3b the profiles of three eryth- protoporphyna patient with a putative cholestatic liver.
ropoietic protoporphyria patients (EPP) are shown, whereas in fig- » »
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Tab. l Survey of the porphyrin analyses of A-, B-, and C-bile
from patients who underwent a duodenal Intubation.
Mean Medi n Minimal Maximal
Coproporphyrin I
(nmol/1)
A-bile(n = 11)
B-bile (n = 9)
C-bile (n = 10)
Copropoφhyrin III
(nmol/1)
A-bile
B-bile
C-bile
Protoporphyrin
(nmol/1)
A-bile
B-bile
C-bile
Copro I/copro I + III
A-bile
B-bile
C-bile
158
249
139
71
77
47
9
11
12
103
244
111
30
87
36
<0.5
6
6
0.76 0.79
0.76 0.80
0.75 0.79
31
83
27
11
33
11
<0.5
<0.5
<0.5
0.48
0.50
0.47
378
363
309
411
147
134
22
29
32
0.86
0.88
0.82
Copro I/protoporphyrin
A-bile
B-bile
C-bile
18
26
18
- -
13
18
30
48
28
terminal liver failure, requiring orthotopic liver trans-
plantation for survival. The fact that bile can be obtained
from orthotopic liver transplantation patients during the
first weeks after the Operation enabled us to compare the
biliary porphyrin excretion, in particular of orthotopic
liver transplantation, of three transplanted erythropoietic
protoporphyria patients with that of some non-erythro-
poietic protoporphyria patients. As shown by the chro-
matograms in figure l and the quantitative data in figure
3 (time course of porphyrin concentrations in the bile
of 3 erythropoietic protoppiphyria patients and 3 non^·
erythropoietic protoporphyria patients after orthotopic
liver transplantation), biliary protoporphyrin is always
much higher in erythropoietic protoporphyria patients
than in non-erythropoietic protoporphyria patients (in
quantitative terms rnore than a hundred fold), whereas
biliary coproporphyrin l and III excretion in erythropoi-
etic protoporphyria patients is only slightly higher.
These results clearly dempnstrate that in erythropoietic
protoporphyria the high amounts of protoporphyrin
mainly originate from the eiythropoietic System in bone
marrow. Fig re 3 also shows that in the first 5 days after
orthotopic liver transplantation both copropoiphyrins
and protoporphyrin are excreted in huge amounts, which
then retura to very low values, later tending to rise
somewhat again. The reason for the strikingly raised bil-
iaiy porphyrin excretion in the first days after orthotopic
liver transplantation cannot be given with certainty and
is the subject of further study. It might be ascribed to
the accumulation of porphyrins produced in the donor
liver in the period between its removal and the time that
transplantation took place and/or to the accumulation of
porphyrins in the host during the Operation phase. After
transplantation these accumulated porphyrins could then
be washed out. After approximately 5 days, a new
steady state Situation is attained, in which the production
and excretion of porphyrins match again, and this wash-
out would no longer occur. To our knowledge, porphy-
rins are the only compounds excreted in highly increased
amounts immediately after orthotopic liver transplanta-
tion (15).
During the 5—15 days after orthotopic liver transplanta-
tion a temporary difficulty in excretion of porphyrins
might be the case, or a low porphyrin de novo synthesis
due to liver regeneration, thus explaining the relatively
low biliary excretion of porphyrins in that period. How-
ever, in two of the three erythropoietic protoporphyria
patients, 10-15 days after orthotopic liver transplanta-
tion, protoporphyrin values show a sustained rise to very
high levels, which vary greatly in individual patients
from day to day.
The third erythropoietic protoporphyria patient (see fig.
3) continuously excreted considerably less protoporphy-
rin than the other two erythropoietic protoporphyria pa-
tients, despite high protoporphyrin concentrations in
blood (15 μηιοΐ/ΐ, normal < 0.56 μηιοΙ/1). Also his pro-
toporphyrin concentrations in serum were increased
(data not shown), reflecting the absence of good liver
function (18). He had severe cholesterasis and died half
a year after orthotopic liver transplantation. Retrospec-
tively it can be stated that even from the Start of or-
thotopic liver transplantation he probably had difficulties
in adeq ately excreting protoporphyrin, leading to an ac-
cumulation of protoporphyrin, which in turn contributed
to early liver failure (18). Protoporphyrin was undetect-
able in the serum of the other orthotopic liver transplan-
tation patients and the other two erythropoietic proto-
porphyria patients, using our method, which has a detec-
tion limit of < 0.5 nmol/1 (data not shown).
The complete absence of deutero-, pempto- and meso-
porphyrins in the bile of orthotopic liver transplantation
patients (see fig. 1) s well s in A-, B- and C-bile (chro-
matograms not shown) motivated us to investigate the
question of whether or not an enterohepatic circulation
of porphyrins operates in humans. These latter porphy-
rins are produced in the gut s a result of reductive con-
version of protoporphyrin by anaerobic bacteria and are
markedly present in faeces (3, 19, 20). If an enterohepa-
tic circulation exists, there should be evidence of these
"seeondary" porphyrins in serum and bile, analogous to
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the presence of secondary bile acids (deoxycholic acid
and lithocholic acid) in serum and bile, produced in the
gut by bacterial conversion of primary bile acids (cholic
acid and chenodeoxycholic acid). In the literature the
enterohepatic circulation of porphyrins constitutes a
controversial issue. Some reports state that such a circu-
lation exists (11-13), whereas others state the reverse
(14). It might be that secondary porphyrins are present
in bile or serum in trace amounts. To exclude this possi-
bility we worked up portions of 50 ml of collected bile
and 100 ml of pooled serum, each with and withqut in-
ternal Standard (deuteroporphyrin). As figures 2a-d de-
monstrate, even in the concentrated extracts of bile and
serum no traces of secondary porphyrins could be de-
tected, which does not support the hypothesis that por-
phyrins are subject to enterohepatic circulation at the
lower part of the gastrointestinal tract. This finding does
not exclude the presence of an enterohepatic circulation
of copro- and uroporphyrins nor the absorption of proto-
porphyrifi · at the upper part of the gut. In one of our
previous studies it was demonstrated that in normal sub-
jects more than 90% of the primary porphyrins in faeces
(protoporphyrin and coproporphyrins) and all of the se-
condary porphyrins are synthesized by bacteria in the
lower part of the small bowel and colon (3). Since dicar-
boxylic porphyrins are not absorbed in these parts, the
total enterohepatic circulation of porphyrins at the upper
part of the gastrointestinal tract, if existent, would be
relatively small under normal conditions, due to the low
biliary concentrations of porphyrins.
Finally, we analysed the porphyrin composition of A-,
B- and C-bile from various patients not suffering from
any of the porphyrias (see tab. 1). First of all, it is obvi-
ous that the concentration of porphyrins in these bile
samples varies widely. The patterhs of A-, B- and C-
bile, which show close resemblance with those of bile
obtained ftom (non-erythropoietic protoporphyria) or-
thotopic liver transplantation patients, are not essentially
different, although the liiean coficentrations in B-bile are
higher than in A- and C-bile. Apart from two unknown
compounds ("peaks 5 and 6") coproporphyrins I and III,
and protoporphyrin are present. Coproporphyrin I is al-
most always the prominent biliary porphyrin and its eoii-
centration far exceeds that of protoporphyrin, the latter
not exceeding a value of approximately 30 nmol/1. The
overall mean ratios coproporphyrin I/coproporphyrin I
and ΠΙ (copro I ratio) and coproporphyrin I/protopor-
phyrin are 0.76 and 21, respectively. The same results in
bile have been previously reported (21, 22). Similar
copro I ratios also are detected in faeces (2, 22). Only
in one case was a copro I ratio of less than 0.50 (copro-
porphyrin ΙΙί concentration exceeding that of copropor-
phyrin I) found. In contrast to bile, normal faecal proto-
porphyrin concentrations (and its derivatives deutero-,
pempto- and ^ε$οροφ1ι;ντίη) often markedly exceed
those of coproporphyrin I. This can be attributed to both
bacterial prod ction and conversion of protoporphyrin
in the gut (3, 19, 20).
To summarize, the profiling of porphyrins in bile reveals
interesting aspects of their hepatic clearance, and shows
that their quantitative determination can be of value in
some clinical situations, e.g. the follow up of protopor-
phyrin excretion in erythropoietic protoporphyria pa-
tients after orthotopic liver transplantation. The absence
of secondary porphyrins in bile (and serum) suggests the
absence of an enterohepatic circulation for dicarboxylic
porphyrins.
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